Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 31722-560

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 31722-560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber-logo (Camber Logo)

FDA Label Image

Cont-label (Cont Label)

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg by Camber Pharmaceuticals, Inc. The film-coated tablet package contains 30 tablets for oral use. Manufacturer details include Hetero Labs Limited, India. The label includes storage instructions and a pharmacist warning to dispense the Medication Guide separately.*

FDA Label Image

Structure-1 (Structure 1)

Chemical structure diagram of emtricitabine, one of the active ingredients in Emtricitabine and tenofovir disoproxil fumarate tablets. The structure shows the molecular arrangement of atoms including nitrogen, oxygen, fluorine, and sulfur.*

FDA Label Image

Structure-2 (Structure 2)

Chemical structure of emtricitabine and tenofovir disoproxil fumarate, depicting molecular bonds and atom arrangements for the active ingredients in the tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.